GB-Salisbury: Pharmaceutical In Vitro Protein binding and blood partitioning Study
What the buyer wrote
The project is developing a medicinal product. As such it is planned to administer the two active pharmaceutical ingredients (APIs) of interest to humans in clinical trials. To maximise the understanding of how these APIs behave when administered to humans it is important to gain knowledge of their binding to plasma proteins and blood components. The results from these assays will be used to improve the understanding of the pharmacokinetics of these drugs as the project progresses. This requirement is for the in vitro assessment of plasma protein binding and whole blood to plasma ratio of the two APIs being developed in this project separately and in combination. Additional information: T…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- GB-Salisbury: Pharmaceutical In Vitro Protein binding and blood partitioning Study
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Work starts
- 27 May 2018
- Work ends
- 8 Oct 2018
- Kind of work
- Pharmacy and medicines
Who the buyer named
Commercial services was the named contact on this notice.